Position in LNTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$73,893,828
+$6,387,572 QoQ
Shares Held
974,210
-4.0% QoQ
Ownership
1.50%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Derivatives in LNTH
reported options exposure · as of Mar 31, 2026CallValue
$386,835
CallShares
5,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $418,627,713 across 21 Drug Manufacturers - Specialty & Generic names. LNTH ranks #2 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
149,303 | $88,533,692 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
This page
|
974,210 | $73,893,828 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,318,555 | $68,156,107 | |
| 4 | HLN |
Haleon plc
|
6,574,038 | $65,806,120 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,130,507 | $34,050,870 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
640,958 | $30,862,127 | |
| 7 | VTRS |
Viatris Inc
|
1,777,181 | $24,009,715 | |
| 8 | ADCT |
ADC Therapeutics SA
|
3,382,129 | $12,682,983 |
All Filings in LNTH
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $386,835 | 5,100 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $73,893,828 | 974,210 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $67,506,256 | 1,014,369 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $1,504,030 | 22,600 | Call | Defined | 2026-02-17 | |
| 2024-09-30 | $1,911,954 | 17,421 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $26,794,057 | 333,716 | Shares | Defined | 2024-09-16 | |
| 2023-12-31 | $6,200,000 | 100,000 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $7,665,556 | 123,638 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $42,881,994 | 519,404 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $28,042,166 | 550,278 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $42,345,765 | 641,311 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $50,483,040 | 912,729 | Shares | Defined | 2022-05-16 | |
| 2021-06-30 | $10,136,030 | 366,716 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||